Medical problems of the genitourinary system can include a range of disorders such as congenital anomalies, infectious diseases, trauma or conditions that involve the urinary structure or function. Of particular interest as drug development targets are the kidneys, ureters, bladder, urethra and prostate.
BREPROCELL Biopta’s (now part of our Centre for Predictive Drug Discovery) have extensive experience assessing contractile and relaxatory responses in fresh human tissues, including bladder, prostate and urethra. Ex vivo assays using bladder and other tissues are also feasible. Furthermore, human genitourinary tissue specimens are available from REPROCELL’s BioServe tissue resources.
Predictive Drug Discovery Assay Services
Online Resources
22-25 March 2021 / Virtual Meeting
We are participating in Europe’s largest Springtime Biotech Partnering Digital Event. Please schedule a virtual meeting with us!
REPROCELL
Products
Services
© 2021 REPROCELL Inc. All rights reserved.
REPROCELL Inc. 日本語 MetLife Shin-yokohama 381, Bldg. 9F, 3-8-11 Shin-yokohama, Kohoku-ku, Yokohama, Kanagawa 222-0033, Japan
REPROCELL USA Inc. 9000 Virginia Manor Road, Suite 207, Beltsville, 20705, USA
REPROCELL Europe Ltd. Thomson Pavilion, Todd Campus, West of Scotland Science Park, Acre Road, Glasgow, G20 0XA, United Kingdom
Bioserve Biotechnologies (India) PVT Ltd. Unit: D4-D7, 1st Floor, Industrial Estate, Moula Ali, Medchal-Malkajgiri Dist., Hyderabad-500040, Telangana, India